ArticleGeroScience2026
Assessment of surface EMG biomarkers in sarcopenic motor dysfunction during postural stabilization.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuromuscular characteristics of dynamic balance control in patients with sarcopenia: a combined analysis of surface electromyography and limits of stability.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to investigate neuromuscular adaptations in individuals with pre/sarcopenia during postural balance perturbations, using surface electromyography (sEMG) signal features as potential functional biomarkers of early motor decline.
methodsTwenty-eight older adults (14 pre/sarcopenic, 14 controls) were subjected to a series of forward balance perturbations while standing on a force platform. sEMG signals were recorded from four lower limb muscles and analyzed across five defined postural epochs established by the perturbation. Six sEMG features were extracted to capture amplitude, frequency, shape, and complexity characteristics of the signals. Linear mixed-effects models were used to evaluate group differences and trial-by-trial adaptation.
resultsThe Post-stab epoch (350-2350 ms post-perturbation) revealed the most pronounced differences between groups. The pre/sarcopenic group exhibited significantly lower amplitude and complexity values. Additionally, shape analysis showed a distribution more closely resembling a Laplacian profile in the pre/sarcopenic group, indicative of increased motor unit synchronization and diminished recruitment variability.
conclusionThis study identifies specific sEMG-derived features, particularly signal shape and complexity metrics, as potential non-invasive biomarkers for neuromuscular decline in sarcopenia. The Post-stab epoch emerges as a sensitive window for detecting deficits in motor control, supporting the use of perturbation-based tasks and sEMG analysis for early detection, monitoring, and intervention planning in aging populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.